Rentosertib

Technology

• Insilico AI-designed drug reverses biological aging markers in trial: A Nature Biotechnology study indicates that rentosertib, an AI-designed drug by Insilico Medicine, may reverse biological aging markers. In a 42-patient trial, six independent aging clocks predicted treated patients were biologically up to six years younger than the placebo group.

  Biotech • The Decoder

  Permalink